Association of treatment satisfaction and physician trust with glycemic control among primary care patients with type 2 diabetes in Egypt
- 18 August 2023
- journal article
- research article
- Published by Springer Nature in Diabetology International
- Vol. 15 (1) , 67-75
Abstract
Objectives To evaluate the association of diabetes treatment satisfaction and trust in family physicians with glycemic control among primary care patients with type 2 diabetes mellitus. Methods A cross-sectional study on 319 patients with type 2 diabetes mellitus from five primary healthcare centers in Egypt. Data were collected from February to August 2021 using a structured questionnaire that contained six parts: sociodemographic data, disease profile, the Diabetes Treatment Satisfaction Questionnaire (DTSQ), 8-item Morisky Medication Adherence Scale (MMAS-8), self-reported medication knowledge questionnaire (MKQ), and revised healthcare relationship trust scale (HCR). Multiple linear regression analysis was used to assess predictors of treatment satisfaction, physician trust, and HbA1c level. P values less than 0.05 were considered significant. Results The mean age was 59.66 years (± 7.87 years) and 55.17% were females. Multiple linear regression analysis for predicting HbA1c showed that HbA1c level was lower in patients with higher treatment satisfaction scores (β = − 0.289, p < 0.001) and higher medication adherence scores (β = − 0.198, p = 0.001). Treatment satisfaction scores were positively predicted by higher physician trust scores (β = 0.301, p < 0.001), increased medication adherence scores (β = 0.160, p = 0.002), and longer duration of diabetes (β = 0.226, p < 0.001). Positive predictors for physician trust included HbA1c level (β = 0.141, p = 0.012), medication knowledge (β = 0.280, p < 0.001), diabetes treatment satisfaction (β = 0.366, p < 0.001) and medication adherence (β = 0.146, p = 0.011). Conclusion Optimizing diabetes treatment satisfaction and physician trust could have favorable associations with medication adherence and medication knowledge with a possible improvement in glycemic control. Family physicians should incorporate patients reported outcomes alongside traditional clinical measures in evaluating diabetes management in primary care.Keywords
This publication has 30 references indexed in Scilit:
- Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugsClinicoEconomics and Outcomes Research, 2013
- Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetesPrimary Care Diabetes, 2013
- The Chronic Care Model and Diabetes Management in US Primary Care Settings: A Systematic ReviewPreventing Chronic Disease, 2013
- Measuring patient–provider trust in a primary care population: Refinement of the health care relationship trust scaleResearch in Nursing & Health, 2012
- Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfactionPrimary Care Diabetes, 2012
- Treatment satisfaction of diabetic patients: what are the contributing factors?Family Practice, 2009
- The effects of trust in physician on self-efficacy, adherence and diabetes outcomesSocial Science & Medicine, 2009
- Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and AdherenceClinical Medicine & Research, 2008
- Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient SettingThe Journal of Clinical Hypertension, 2008
- Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 DiabetesDiabetes Care, 2002